| Name | Title | Contact Details |
|---|
Progress is achieved by those with the courage to reimagine whats possible. Audi was born more than a century ago with a vision of boldly challenging the status quo and is bound by a promise to imaginatively innovate. We believe the best ideas—the ideas that will define our future—will come from new ways of thinking. We believe everyone should have a voice. We believe in equality. We believe that "we" includes all of us. For these reasons, we strive to create a workplace where diverse ideas are embraced, where people can be themselves, and where everyone comes together to reinvent mobility, drive toward a more sustainable future and create amazing customer experiences.
TICA group middle east is the branch and after-sale service center of TICA Air condition in the middle east, TICA is one of the leading manufacturers of HVAC (Heating, Ventilation and Air Conditioning) equipment in the world. #HVAC #VRF #CHILLER #DX
In 1990, Nitro Snowboards was founded by Thomas Delago and Sepp Ardelt in Seattle, Washington. Over the last 25 years Nitro has helped grow the sport of snowboarding through its groundbreaking product development, marketing, movies, grass roots events, and global team of world class snowboarders. Today Nitro has grown its product to offer all the essentials needed for having a good time snowboarding and traveling. Nitro´s headquarters are divided all over the world from the Mountains of Oberammergau, to the worlds best snow in Salt Lake City, UT, to the creative beaches of California, all the way up to the Northwest snowboarding destination of Vancouver, British Colombia. For more information visit us at http://www.nitrosnowboards.com or @NITROUSA on Instagram
MedChemExpress offers a wide range of high-quality life science biochemicals, including novel bioactive compounds, recombinant proteins, dye reagents, peptides and natural compounds for laboratory and scientific use. We take pride in offering only the highest-grade products. Product identity, quality, purity and activity are assured by our robust quality control programs and procedures. We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.